Metabolism of thioridazine by microsomal monooxygenases: relative roles of P450 and flavin-containing monooxygenase

References

• Atta-Asafo-Adjei E., Lawton M. P., Philpot R. M. Cloning, sequencing, distribution, and expression in Escherichia coli of flavin-containing monooxygenase 1C1. Evidence for a third gene subfamily in rabbits. Journal of Biological Chemistry 1993; 268: 9681–9689
   PubMed Web of Science ®Google Scholar
• Baba T., Yamada H., Oguri K., Yoshimura H. Studies on N-demethylation of methaphetamine by means of purified guinea-pig liver flavin-containing monooxygenase. Biochemical Pharmacology 1987; 36: 4171–4173
   PubMed Web of Science ®Google Scholar
• Bickel M. H. The pharmacology and biochemistry of N-oxides. Pharmacology Reviews 1969; 21: 325–355
   PubMed Web of Science ®Google Scholar
• Bolen P., Stein S., Dairmen W., Udenfriend S. Fluorometric assay of proteins in the nanogram range. Archives of Biochemistry and Biophysics 1973; 155: 213–220
   PubMed Web of Science ®Google Scholar
• Burnktt V. L., Lawton M. P., Philpot R. M. Cloning and sequencing of flavin-containing monooxygenases FMO3 and FMO4 from rabbit and characterization of FMO3. Journal of Biological Chemistry 1994; 269: 14314–14322
   PubMed Web of Science ®Google Scholar
• Cashman J. R., Yang Z., Yang L., Wrighton S. A. Stereo- and regioselective N- and S-oxidation of tertiary amines and sulfides in the presence of adult human liver microsomes. Drug Metabolism and Disposition 1993; 21: 492–501
   PubMed Web of Science ®Google Scholar
• Clement B., Lustig K. L., Ziegler D. M. Metabolism of promethazine catalyzed by porcine liver flavin-containing monooxygenase. Progress in Pharmacology and Clinical Pharmacology 1991; 8: 127–136
   Google Scholar
• Clement B., Lustig K. L., Ziegler D. M. Oxidation of desmethylpromethazine catalyzed by pig liver flavin-containing monooxygenase. Number and nature of metabolites. Drug Metabolism and Disposition 1993; 21: 24–29
   PubMed Web of Science ®Google Scholar
• Craig J. C., Dwyer F. P., Glazer A. N., Horning E. C. Tertiary amine oxide rearrangements. I. Mechanism. Journal of the American Chemical Society 1961; 83: 1871–1874
   Web of Science ®Google Scholar
• Craig J. C., Mary N. Y., Roy S. K. Application of gas chromatography to the detection of tert-amine oxides. Analytical Chemistry 1964; 36: 1142–1143
   Web of Science ®Google Scholar
• Craig J. C., Purushothaman K. K. An improved preparation of tertiary amine N-oxides. Journal of Organic Chemistry 1970; 35: 1721–1722
   PubMed Web of Science ®Google Scholar
• Curry S. H., Evans S. A note on the assay of chlorpromazine N-oxide and its sulphoxide in plasma and urine. Journal of Pharamaceutical Pharmacology 1976; 28: 467–468
   PubMed Web of Science ®Google Scholar
• Dahl S. G. Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects. Therapeutic Drug Monitoring 1982; 4: 33–40
   PubMed Web of Science ®Google Scholar
• Dlxit A., Roche T. E. Spectrophotometric assay of the flavin-containing monooxygenase and changes in its activity in female mouse liver with nutritional and diurnal conditions. Archives of Biochemistry and Biophysics 1984; 233: 50–63
   PubMed Web of Science ®Google Scholar
• Dolphin C., Shephard E. A., Povey S., Palmer C. N. A., Ziegler D. M., Ayesh R., Smith R. L., Phillips I. R. Cloning, primary sequence, and chromosomal mapping of a human flavin-containing monooxygenase (FMO 1). Journal of Biological Chemistry 1991; 266: 12379–12385
   PubMed Web of Science ®Google Scholar
• Dolphin C. T., Shephard E. A., Povey S., Smith R. L., Phillips I. R. Cloning, primary sequence and chromosomal localization of human FMO2, a new member of the flavin-containing mono-oxygenase family. Biochemical Journal 1992; 287: 261–267
   PubMed Web of Science ®Google Scholar
• Duxbar B. S., Schwoebel E. D. Preparation of polyclonal antibodies. Methods in Ertzymology, Vol. 182, M. P. Deutscher. Academic, Orlando 1990; 663–670
   Google Scholar
• Eap C. B., Souche A., Koeb L., Baumann P. Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine. Therapeutic Drug Monitoring 1991; 13: 356–362
   PubMed Web of Science ®Google Scholar
• Essien E. E., Cowan D. A., Beckett A. H. Metabolism of phenothiazines: identification of N-oxygenated products by gas chromatography and mass spectrometry. Journal of Pharamaceutical Pharmacology 1975; 27: 334–342
   PubMed Web of Science ®Google Scholar
• Fuller R. W., Snoddy H. D., Slater I. H. Metabolic interactions between nortriptyline and thioridazine in rats. Toxicology and Applied Pharmacology 1974; 29: 259–269
   PubMed Web of Science ®Google Scholar
• Gay P. E., Madsen J. A. Interaction between phenobarbital and thioridazine. Neurology 1983; 33: 1631–1632
   PubMed Web of Science ®Google Scholar
• Gottschalk L. A., Dinovo E., Biener R., Nandi B. R. Plasma concentrations of thioridazine metabolites and ECG abnomalities. Journal of Pharmaceutical Sciences 1978; 67: 155–157
   PubMed Web of Science ®Google Scholar
• Gut I., Conney A. H. Trimethylamine N-oxygenation and N-demethylation in rat liver microsomes. Biochemical Pharmacology 1993; 46: 239–244
   PubMed Web of Science ®Google Scholar
• Hale P. W., Poklis A. Thioridazine 5-sulfoxide diastereoisomers in serum and urine from rats and man after chronic administration. Journal of Analytical Toxicology 1985; 9: 197–201
   PubMed Web of Science ®Google Scholar
• Hale P. W., Poklis A. Cardiotoxicity of thioridazine and two stereoisometric forms of thioridazine 5-sulfoxide in the isolated perfused rat hear. Toxicology and Applied Pharmacology 1986; 86: 44–55
   PubMed Web of Science ®Google Scholar
• Haktman F., Gruknke L. D., Craig J. C., Bissell D. M. Chlorpromazine metabolism in extracts of liver and small intestine from guinea pig and from man. Drug Metabolism and Disposition 1983; 11: 244–248
   PubMed Web of Science ®Google Scholar
• Hubrard J. W., Cooper J. K., Hawes E. M., Jenden D. J., May P. R. A., Martin M., McKay G., Van Putten T., Midha K. K. Therapeutic monitoring of chlorpromazine. I. Pitfalls in plasma analysis. Therapeutic Drug Monitoring 1985; 7: 222–228
   PubMed Web of Science ®Google Scholar
• Juenge E. C., Wells C. E., Green D. E., Forrest I. S., Shoolery J. N. Synthesis, isolation, and characterization of two stereiosomeric ring sulfoxides of thioridazine. Journal of Pharmaceutical Sciences 1983; 72: 617–621
   PubMed Web of Science ®Google Scholar
• Kilts C. D., Knight D. L., Mailman R. B., Widerlov E., Breese G. R. Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine. Journal of Pharmacology and Experimental Therapeutics 1984; 231: 334–342
   PubMed Web of Science ®Google Scholar
• Kilts C. D., Patrick K. S., Breese G. R., Mailman R. B. Simultaneous determination of thioridazine and its S-oxidized and N-demethylated metabolites using high-performance liquid chromatography on radially compressed silica. Journal of Chromatography 1982; 231: 377–391
   PubMed Web of Science ®Google Scholar
• Kinsler S., Levi P. E., Hodgson E. Hepatic and extrahepatic microsomal oxidation of phorate by the cytochrome P450 and FAD-containing monooxygenase systems in the mouse. Pesticide Biochemistry and Physiology 1988; 31: 54–60
   Web of Science ®Google Scholar
• Koop D. R. Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Molecular Pharmacology 1986; 29: 399–404
   PubMed Web of Science ®Google Scholar
• Lawton M. P., Philpot R. M. Emergence of the flavin-containing monooxygenase gene family. Reviews in Biochemical Toxicology, vol. 11, E. Hodgson, R. M. Philpot, J. R. Bend. Toxicology Communications, Inc., Raleigh, N.C. 1995; 1–27
   Google Scholar
• Lewis M. H., Widerlov E., Knight D. L., Kilts C. D., Mailman R. B. N-oxides of phenothiazine antipsychotics: effects on in vivo and in vitro estimates of dopaminergic function. Journal of Pharmacology and Experimental Therapeutics 1983; 225: 539–545
   PubMed Web of Science ®Google Scholar
• Lin G., Hawes E. M., McKay G., Korchinski E. D., Midha K. K. Metabolism of piperidine-type phenothiazine antipsychotic agents. IV. Thioridazne in the dog, man and rat. Xenobiotica 1993; 23: 1059–1074
   PubMed Web of Science ®Google Scholar
• Lomri N., Gu Q., Cashman J. R. Molecular cloning of the flavin-containing monooxygenase (form II) cDNA from adult human liver. Proceedings of the National Academy of Sciences, USA 1992; 89: 1685–1689
   PubMed Web of Science ®Google Scholar
• Lomki N., Thomas J., Cashman J. R. Expression in Escherichia coli of the cloned flavin-containing monooxgenase from pig liver. Journal of Biological Chemistry 1993a; 268: 5048–5054
   PubMed Web of Science ®Google Scholar
• Lomri N., Yang Z., Cashman J. R. Regio-and stereoselective oxygenations by adult human liver flavin-containing monooxygenase 3. Comparison with forms 1 and 2. Chemical Research in Toxicology 1993b; 6: 800–807
   PubMed Web of Science ®Google Scholar
• Lomri N., Yang Z., Cashman J. R. Expression in Escherichia coli of the flavin-containing monooxygenase D (form II) from adult human liver: determination of a distinct tertiary amine substrate specificity. Chemical Research in Toxicology 1993c; 6: 425–429
   PubMed Web of Science ®Google Scholar
• Lubet R. A., Mayer R. T., Cameron J. W., Nims R. W., Burke M. D., Wolff T., Guengerich F. P. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P450 by phenobarbital and other xenobiotics in the rat. Archives of Biochemistry Biophysics 1985; 238: 43–48
   PubMed Web of Science ®Google Scholar
• Martensson E., Nyberg G., Axelsson R., Serck-Hansen K. Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients. Current Therapeutic Research 1975; 18: 687–700
   PubMed Web of Science ®Google Scholar
• Masters B. S. S., Ziegler D. M. The distinct nature and function of NADPH-cytochrome c reductase and the NADPH-dependent mixed-function amine oxidase of porcine liver microsomes. Archives of Biochemistry and Biophysics 1971; 145: 358–364
   PubMed Web of Science ®Google Scholar
• Meyer J. W., Woggon B., Baumann P., Meyer U. A. Clinical implications of slow sulphoxidation of thioridazine in a poor metabolizer of the debrisoquine type. European Journal of Clinical Pharmacology 1990; 39: 613–614
   PubMed Web of Science ®Google Scholar
• Murray M., Reidy G. F. In vitro inhibition of hepatic drug oxidation by thioridazine. Kinetic analysis of the inhibition of cytochrome P-450 isoform-specific reactions. Biochemical Pharmacology 1989; 38: 4359–4365
   PubMed Web of Science ®Google Scholar
• Muusze R. G., Huber J. F. K. Determination of the psychotropic drug thioridazine and its metabolites in blood by means of high pressure liquid chromatography in combination with fluorometric reaction detection. Journal of Chromatographic Science 1974; 12: 779–787
   PubMed Web of Science ®Google Scholar
• Nagata T., Williams D. E., Ziegler D. M. Substrate specificities of rabbit lung and porcine liver flavin-containing monooxygenases: differences due to substrate size. Chemical Research in Toxicology 1990; 3: 372–376
   PubMed Web of Science ®Google Scholar
• Ng C. H., Crammer J. L. Measurement of thiordazine in blood and urine. British Journal of Clinical Pharmaclogy 1977; 4: 173–183
   PubMed Web of Science ®Google Scholar
• Niedzwiecki D. M., Cubeddu L. X., Mailman R. B. Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum. Journal of Pharmacology and Experimental Therapeutics 1989; 250: 117–125
   PubMed Web of Science ®Google Scholar
• Niedzwiecki D. M., Mailman R. B., Cubbedu L. X. Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors. Journal of Pharmacology and Experimental Therapeutics 1984; 228: 636–639
   PubMed Web of Science ®Google Scholar
• Okey A. B. Enzyme induction in the cytochrome P450 system. Pharmacology and Therapeutics 1990; 45: 241–298
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification and properties. Journal of Biological Chemistry 1964; 239: 2379–2385
   PubMed Web of Science ®Google Scholar
• Papadopoulos A. S., Crammer J. L. Suphoxide metabolites of thioridazine in man. Xenobiotica 1986; 16: 1097–1107
   PubMed Web of Science ®Google Scholar
• Papadopoulos A. S., Crammer J. L., Cowan D. A. Phenolic metabolites of thioridazine in man. Xenobiotica 1985; 15: 309–316
   PubMed Web of Science ®Google Scholar
• Rose R. L., Brindley W. A. An evaluation of the role of oxidative enzymes in Colorado potato beetle resistance to carbamate insecticides. Pesticide Biochemistry and Physiology 1985; 23: 74–84
   Web of Science ®Google Scholar
• Sabourin P. J., Smyser B. P., Hodgson E. Purification of the flavin-containing monooxygenase from mouse and pig liver microsomes. International Journal of Biochemistry 1984; 16: 713–720
   PubMedGoogle Scholar
• Sofer S. S., Ziegler D. M. Microsomal mixed function amine oxidase. Oxidation products of piperazine-substituted phenothiazine drugs. Drug Metabolism and Disposition 1978; 6: 232–239
   PubMed Web of Science ®Google Scholar
• Svensson C., Nyberg G., Soomagi M., Martensson E. Determination of the serum concentrations of thioridazine and its main metabolites using a solid-phase extraction technique and high-performance liquid chromatography. Journal of Chromatography 1990; 529: 229–236
   PubMed Web of Science ®Google Scholar
• Syvalahti E. K. G., Lindberg R., Kallio J., De Vocht M. Inhibitory effects of neuroleptics on debrisoquine oxidation. British Journal of Clinical Pharmacology 1986; 22: 89–92
   PubMed Web of Science ®Google Scholar
• Tavoloni N., Boyer J. L. Relationship between hepatic metabolism of chlorpromazine and cholestatic effects in the isolated pefused rat liver. Journal of Pharmacology and Experimental Therapeutics 1980; 214: 269–274
   PubMed Web of Science ®Google Scholar
• Traficante L. J., Siekierski J., Sakalis G., Gershon S. Sulfoxidation of chlorpromazine and thioridazine by bovine liver. Preferential metabolic pathways. Biochemical Pharmacology 1979; 28: 621–626
   PubMed Web of Science ®Google Scholar
• Tyczkowska K., Voyksner R. D., Aronson A. L. Development of an analytical method for penicillin g in bovine milk by liquid chromatography with ultraviolet-visible detection and confirmation by mass spectrometric detection. Journal of Chromatography 1989; 490: 101–113
   PubMed Web of Science ®Google Scholar
• Venkatesh K., Levi P. E., Hodgson E. The flavin-containing monooxygenase of mouse kidney. A comparison with the liver enzyme. Biochemical Pharmacology 1991; 42: 1411–1420
   PubMed Web of Science ®Google Scholar
• Vincent F. M. Phenothiazine-induced phenytoin intoxication. Annals of Internal Medicine 1980; 93: 56–57
   PubMed Web of Science ®Google Scholar
• Von Bahr C., Movin G., Nordin C., Liden A., Hammarlund-Udenaes M., Hedberg A., Ring H., Sjoquist F. Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype. Clinical Pharmacology and Therapeutics 1991; 49: 234–240
   PubMed Web of Science ®Google Scholar
• Von Bahr C., Spina E., Birgersson C., Ericsson O., Goransson M., Henthorn T., Sjoqvist F. Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes. Biochemical Pharmacology 1985; 34: 2501–2505
   PubMed Web of Science ®Google Scholar
• Watkins G. M., Whelpton R., Buckley D. G., Curry S. H. Chromatographic separation of thioridazine sulphoxide and N-oxide diastereoisomers: identification as metabolites in the rat. Journal of Pharmaceutical Pharmacology 1986; 38: 506–509
   PubMed Web of Science ®Google Scholar
• Wrighton S. A., Stevens J. C. The human hepatic cytochromes P450 involved in drug metabolism. Critical Reviews in Toxicology 1992; 22: 1–21
   PubMed Web of Science ®Google Scholar
• Zehnder K., Kalberer F., Kreis W., Rutschmann J. The metabolism of thioridazine (Mellaril) and one of its pyrrolidine analogues in the rat. Biochemical Pharmacology 1962; 11: 535–550
   PubMed Web of Science ®Google Scholar
• Ziegler D. M. Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metabolism Reviews 1988; 19: 1–32
   PubMed Web of Science ®Google Scholar
• Ziegler D. M. Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases. Annual Review of Pharmacology and Toxicology 1993; 33: 179–199
   PubMed Web of Science ®Google Scholar